Foundation for Innovative New Diagnostics-医療機器分野:企業M&A・提携分析

◆英語タイトル:Foundation for Innovative New Diagnostics - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012884
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions. The organization has its presence in Switzerland, India, Uganda, and South Africa. FIND is headquartered in Geneva, Switzerland.

Foundation for Innovative New Diagnostics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Foundation for Innovative New Diagnostics, Medical Equipment, Deal Details 11
Partnerships 11
Chembio Diagnostics Enters into Agreement with FIND 11
Fujifilm Enters into Co-Development Contract with Foundation for Innovative New Diagnostics 12
Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 13
Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics 14
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 15
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 16
Lumora And FIND Enter Into Agreement To Develop Molecular Diagnostic Test For Malaria 17
Global BioDiagnostics Extends Co-Development Agreement With Foundation for Innovative New Diagnostics 18
FIND Enters Into An Agreement With Global BioDiagnostics 19
Cepheid Enters Into Co-Development Agreement With FIND 20
Foundation for Innovative New Diagnostics – Key Competitors 21
Foundation for Innovative New Diagnostics – Key Employees 22
Foundation for Innovative New Diagnostics – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Foundation for Innovative New Diagnostics, Medical Equipment, Key Facts 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Deals By Market, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Chembio Diagnostics Enters into Agreement with FIND 11
Fujifilm Enters into Co-Development Contract with Foundation for Innovative New Diagnostics 12
Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 13
Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics 14
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 15
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 16
Lumora And FIND Enter Into Agreement To Develop Molecular Diagnostic Test For Malaria 17
Global BioDiagnostics Extends Co-Development Agreement With Foundation for Innovative New Diagnostics 18
FIND Enters Into An Agreement With Global BioDiagnostics 19
Cepheid Enters Into Co-Development Agreement With FIND 20
Foundation for Innovative New Diagnostics, Key Competitors 21
Foundation for Innovative New Diagnostics, Key Employees 22
Foundation for Innovative New Diagnostics, Other Locations 23

★海外企業調査レポート[Foundation for Innovative New Diagnostics-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fujifilm Corp:企業の戦略的SWOT分析
    Fujifilm Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Orange SA:戦略・SWOT・企業財務分析
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Tupperware Brands Corp (TUP):企業の財務・戦略的SWOT分析
    Tupperware Brands Corp (TUP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務情報
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Visa Inc.:戦略・SWOT・企業財務分析
    Visa Inc. - Strategy, SWOT and Corporate Finance Report Summary Visa Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Berkshire Hathaway Energy Co:電力:M&Aディール及び事業提携情報
    Summary Berkshire Hathaway Energy Company (BHE) a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources su …
  • KLA-Tencor Corporation:戦略・SWOT・企業財務分析
    KLA-Tencor Corporation - Strategy, SWOT and Corporate Finance Report Summary KLA-Tencor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Red Hat Inc:企業の戦略的SWOT分析
    Red Hat Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Duopharma Biotech Berhad (DPHARMA):企業の財務・戦略的SWOT分析
    Summary Duopharma Biotech Berhad (Duopharma), formerly CCM Duopharma Biotech Berhad, focuses on research, development and commercialization of generic drugs and biosimilars. The company manufactures and distributes pharmaceutical products to treat oncology and diabetes; musculo-skeletal, alimentary …
  • InvenSense Inc (INVN):企業の財務・戦略的SWOT分析
    Summary InvenSense Inc (InvenSense), a subsidiary of TDK Corp is a technology company that offers sensor systems. The company provides MEMS motion sensors such as gyroscopes, compasses, accelerometers, pressure sensors, and microphones for mobile, wearable, smart home, industrial and automotive mark …
  • Aviragen Therapeutics Inc (AVIR)-製薬・医療分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …
  • PDL BioPharma Inc (PDLI)-医療機器分野:企業M&A・提携分析
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • Bullet Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bullet Biotechnology Inc (Bullet Biotechnology) focuses on the development of immunotherapies for the treatment of cancer. The company’s lead product, BB-006 is under development which is being developed to treat solid tumors. Bullet Biotechnology’s primarily interest in is immuno-oncology a …
  • Physical Sciences Inc:製品パイプライン分析
    Summary Physical Sciences Inc (PSI) is a contract research and development service provider that offers basic research and technology development applications. The company provides products such as ISR systems, laser based sensors, passive sensors and RF and optical components. It produces high gain …
  • Vectura Group plc:企業の戦略・SWOT・財務情報
    Vectura Group plc - Strategy, SWOT and Corporate Finance Report Summary Vectura Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Control4 Corp (CTRL):企業の財務・戦略的SWOT分析
    Control4 Corp (CTRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Vifor Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Vifor Pharma AG (Vifor Pharma) a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tre …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SeraCare Life Sciences Inc:企業の戦略的SWOT分析
    SeraCare Life Sciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Bankers Petroleum Ltd:企業の戦略的SWOT分析
    Bankers Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆